These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. Fuchs M; Goergen H; Kobe C; Kuhnert G; Lohri A; Greil R; Sasse S; Topp MS; Schäfer E; Hertenstein B; Soekler M; Vogelhuber M; Zijlstra JM; Keller UB; Krause SW; Wilhelm M; Maschmeyer G; Thiemer J; Dührsen U; Meissner J; Viardot A; Eich H; Baues C; Diehl V; Rosenwald A; von Tresckow B; Dietlein M; Borchmann P; Engert A J Clin Oncol; 2019 Nov; 37(31):2835-2845. PubMed ID: 31498753 [TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes of combined modality therapy for advanced-stage Hodgkin lymphoma in the PET era: A retrospective study. Chugh S; Panda G; Mokal S; Jain H; Bagal B; Khanna N; Epari S; Punatar S; Nayak L; Gokarn A; Khattry N; Sengar M; Laskar S; Goda JS Indian J Med Res; 2024 Feb; 159(2):193-205. PubMed ID: 38577858 [TBL] [Abstract][Full Text] [Related]
14. Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma. Al-Ibraheem A; Anwer F; Juweid ME; Shagera QA; Khalaf AN; Obeidat S; Mansour A; Ma'koseh M; Halahleh K; Jaradat I; Almasri N; Mansour A Sci Rep; 2022 Oct; 12(1):17702. PubMed ID: 36271128 [TBL] [Abstract][Full Text] [Related]
15. Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study. Barrington SF; Phillips EH; Counsell N; Hancock B; Pettengell R; Johnson P; Townsend W; Culligan D; Popova B; Clifton-Hadley L; McMillan A; Hoskin P; O'Doherty MJ; Illidge T; Radford J J Clin Oncol; 2019 Jul; 37(20):1732-1741. PubMed ID: 31112475 [TBL] [Abstract][Full Text] [Related]
16. Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial. Iannitto E; Minardi V; Gobbi PG; Calvaruso G; Tripodo C; Marcheselli L; Luminari S; Merli F; Baldini L; Stelitano C; Callea V; Petrini M; Angrilli F; Quarta G; Vallisa D; Molica S; Liardo E; Polimeno G; Brugiatelli M; Federico M Clin Lymphoma Myeloma; 2009 Apr; 9(2):138-44. PubMed ID: 19406724 [TBL] [Abstract][Full Text] [Related]
17. Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach. Cheng PTM; Villa D; Tonseth RP; Scott DW; Gerrie AS; Freeman CL; Pickles T; Lo AC; Farinha P; Craig JW; Slack GW; Gascoyne RD; Bénard F; Wilson D; Skinnider B; Connors JM; Sehn LH; Savage KJ Blood Adv; 2021 Sep; 5(18):3647-3655. PubMed ID: 34438445 [TBL] [Abstract][Full Text] [Related]
18. Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma. Song MK; Chung JS; Lee JJ; Jeong SY; Lee SM; Hong JS; Chong A; Moon JH; Kim JH; Lee SM; Kim SJ; Shin HJ Cancer Sci; 2013 Dec; 104(12):1656-61. PubMed ID: 24033666 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy. Kamran SC; Jacene HA; Chen YH; Mauch PM; Ng AK Leuk Lymphoma; 2018 Jun; 59(6):1384-1390. PubMed ID: 28937297 [TBL] [Abstract][Full Text] [Related]
20. Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy. Bartlett NL Am Soc Clin Oncol Educ Book; 2013; ():374-80. PubMed ID: 23714551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]